Patents by Inventor Aaron Badenoch

Aaron Badenoch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhalable dry powder cytidine analogue composition and method of use as a treatment for cancer
    Patent number: 11266599
    Abstract: An embodiment of the present invention provides for a dry powder pharmaceutical composition suitable for dispersion in an aerosol for inhaled administration to a patient with cancer, the composition comprising: a cytidine analogue including salts, solvates, hydrates, and esters thereof; and a pharmaceutically acceptable excipient together forming the dry powder pharmaceutical composition suitable for dispersion in the aerosol for administration via inhalation to the patient with cancer. Another embodiment provides for a method of making the composition and a further embodiment provides for a method a treating a patient in need thereof with the composition.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: March 8, 2022
    Assignee: Lovelace Biomedical Research Institute
    Inventors: Steven A. Belinsky, Philip J. Kuehl, Aaron Badenoch, Michael Burke, Devon Dubose
  • Inhalable Dry Powder Cytidine Analogue Composition and Method of Use as a Treatment for Cancer
    Publication number: 20200368157
    Abstract: An embodiment of the present invention provides for a dry powder pharmaceutical composition suitable for dispersion in an aerosol for inhaled administration to a patient with cancer, the composition comprising: a cytidine analogue including salts, solvates, hydrates, and esters thereof; and a pharmaceutically acceptable excipient together forming the dry powder pharmaceutical composition suitable for dispersion in the aerosol for administration via inhalation to the patient with cancer. Another embodiment provides for a method of making the composition and a further embodiment provides for a method a treating a patient in need thereof with the composition.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Applicant: Lovelace Biomedical Research Institute
    Inventors: Steven A. Belinsky, Philip J. Kuehl, Aaron Badenoch, Michael Burke, Devon Dubose